Table 2 Baseline characteristics
DCB | ICB | PVB | |
|---|---|---|---|
(n = 10) | (n = 10) | (n = 10) | |
Age [years] | 67 ± 10 | 70 ± 9 | 72 ± 8 |
Sex male | 7 (70.0) | 9 (90.0) | 8 (80.0) |
female | 3 (30.0) | 1 (10.0) | 2 (20.0) |
Bodyweight [kg] | 72 ± 8 | 83 ± 8 | 84 ± 9 |
Body height [cm] | 167 ± 8 | 174 ± 8 | 170 ± 6 |
BMI [kg/m2] | 25.9 ± 1.6 | 27.3 ± 2.2 | 29.1 ± 3.4 |
Stenosis | |||
Grade [%] | 81 ± 7 | 82 ± 6 | 82 ± 9 |
Sight left | 5 (50.0) | 5 (50.0) | 5 (50.0) |
right | 5 (50.0) | 5 (50.0) | 5 (50.0) |
asymptomatic | 6 (60.0) | 6 (60.0) | 7 (70.0) |
symptomatic | 4 (40.0) | 4 (40.0) | 3 (30.0) |
ASA II | 6 (60.0) | 6 (60.0) | 5 (50.0) |
III | 4 (40.0) | 4 (40.0) | 5 (50.0) |
Comorbidities | |||
Arterial hypertension | 10 (100.0) | 10 (100.0) | 10 (100.0) |
Diabetes mellitus | 4 (40.0) | 4 (40.0) | 5 (50.0) |
Hyperlipoproteinema | 10 (100.0) | 9 (90.0) | 10 (100.0) |
PAOD | 6 (60.0) | 1 (10.0) | 7 (70.0) |
CAD | 4 (40.0) | 4 (40.0) | 5 (50.0) |
AMI | 1 (10.0) | 1 (10.0) | 2 (20.0) |
Stent | 2 (20.0) | 2 (20.0) | 2 (20.0) |
CABG | 1 (10.0) | 0 (0.0) | 3 (30.0) |
Artrial fibrillation | 1 (10.0) | 0 (0.0) | 0 (0.0) |
COPD | 2 (20.0) | 2 (20.0) | 1 (10.0) |
CKD | 3 (30.0) | 2 (20.0) | 1 (10.0) |
Nicotine abuse | 7 (70.0 | 7 (70.0 | 3 (30.0) |
Alcohol abuse | 5 (50.0) | 3 (30.0) | 0 (0.0) |